Cytocell Limited
Other human health activities · Cambridge
ActiveUnited KingdomIncorporated 2001Private Limited Company
Financial snapshot
Full financialsPeriod ended 2025-03-31GBPcompany accounts
Net assets
£38.37m+£3.43m vs 2024-03-31Cash at bank
£663.56k-£232.40k vs 2024-03-31Turnover
£15.49mLatest reporting periodEmployees
76-1 vs 2024-03-31Balance sheet
GBP · companyCompany record
- Company number
- 04231155
- Incorporated
- 2001-06-08
- Legal form
- Private Limited Company
- Registered office
- OXFORD GENE TECHNOLOGY, 418 CAMBRIDGE SCIENCE PARK, CAMBRIDGE, CB4 0PZ
- SIC codes
- 86900
People & control
View all5Current role holders1Control records without an end date0Outstanding security records
OfficerOther current roles
Shinichi Satodirector
0Kenji Iwakabedirector
0Adrian Smithdirector
4Gregory Williamsdirector
6Anthony Lenhardtsecretary
0Oxford Gene Technology Ip Limited
Activity timeline
- Shinichi Sato appointed
director
- David Oxlade resigned
director
- Naohiko Matsuo resigned
director
- Michael Evans resigned
director
- Kenji Iwakabe appointed
director
- Accounts period ended
GBP · 395 source facts
Connected companies
Open networkCytocell Technologies Limited75–100% shares · 75–100% votes
05475998Capital & security
Public records and extracted accounts. Missing figures are unknown, not zero. Research matches are not necessarily direct awards.